[unable to retrieve full-text content]Reuters - One of the pledges of the Obama administration's healthcare overhaul was to enable cheaper copies of expensive biotech drugs, but the savings may not be as deep or come as quickly as hoped.
Source: http://us.rd.yahoo.com/dailynews/rss/biotech/*http%3A//news.yahoo.com/s/nm/20120305/hl_nm/us_biosimilars
steve williams koch brothers weather phoenix dippin dots triumph the insult comic dog tucson weather tucson weather
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.